-
1
-
-
33947636183
-
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy
-
Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 2007; 39: 425-429.
-
(2007)
Bone Marrow Transplant
, vol.39
, pp. 425-429
-
-
Trifilio, S.M.1
Bennett, C.L.2
Yarnold, P.R.3
McKoy, J.M.4
Parada, J.5
Mehta, J.6
-
2
-
-
33750341078
-
New agents for the treatment of fungal infections: Clinical efficacy and gaps in coverage
-
Spanakis EK, Aperis G, Mylonakis E. New agents for the treatment of fungal infections: Clinical efficacy and gaps in coverage. Clin Infect Dis 2006; 43: 1060-1082.
-
(2006)
Clin Infect Dis
, vol.43
, pp. 1060-1082
-
-
Spanakis, E.K.1
Aperis, G.2
Mylonakis, E.3
-
3
-
-
0036532203
-
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients
-
Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-917.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 909-917
-
-
Marr, K.A.1
Carter, R.A.2
Crippa, F.3
Wald, A.4
Corey, L.5
-
4
-
-
33644490374
-
Comparison of Zygomycosis and fusariosis to invasive aspergillosis among transplant recipients reporting to TRANSNET
-
abstract M-666, American Society for Microbiology: Washington, DC
-
Park BJ, Kontoyiannis DP, Pappas PG, Wannemuehler KA, Anaissie E, Fridkin SK et al. Comparison of Zygomycosis and fusariosis to invasive aspergillosis among transplant recipients reporting to TRANSNET [abstract M-666]. In: Program and Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (Washington). American Society for Microbiology: Washington, DC, 2004, p 411.
-
(2004)
Program and Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (Washington)
, pp. 411
-
-
Park, B.J.1
Kontoyiannis, D.P.2
Pappas, P.G.3
Wannemuehler, K.A.4
Anaissie, E.5
Fridkin, S.K.6
-
5
-
-
1342331879
-
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants
-
Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004; 350: 950-952.
-
(2004)
N Engl J Med
, vol.350
, pp. 950-952
-
-
Marty, F.M.1
Cosimi, L.A.2
Baden, L.R.3
-
6
-
-
4344560388
-
Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis
-
Siwek GT, Dodgson KJ, Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584-587.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 584-587
-
-
Siwek, G.T.1
Dodgson, K.J.2
Magalhaes-Silverman, M.3
Bartelt, L.A.4
Kilborn, S.B.5
Hoth, P.L.6
-
8
-
-
33846807740
-
Posaconazole as salvage therapy in a patient with disseminated zygomycosis: Case report and review of literature
-
Page RL, Schwiesow J, Hilts A. Posaconazole as salvage therapy in a patient with disseminated zygomycosis: Case report and review of literature. Pharmacotherapy 2007; 27: 290-298.
-
(2007)
Pharmacotherapy
, vol.27
, pp. 290-298
-
-
Page, R.L.1
Schwiesow, J.2
Hilts, A.3
-
9
-
-
33846410666
-
Posaconazole orfluconazole for prophylaxis in severe graft-versus-host disease
-
Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR et al. Posaconazole orfluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335-347.
-
(2007)
N Engl J Med
, vol.356
, pp. 335-347
-
-
Ullmann, A.J.1
Lipton, J.H.2
Vesole, D.H.3
Chandrasekar, P.4
Langston, A.5
Tarantolo, S.R.6
|